Your browser doesn't support javascript.
The factors correlated with COVID-19 vaccination coverage in Chinese hypertensive patients managed by community general practitioner.
Liu, Shijun; Jiang, Caixia; Wang, Jun; Liu, Yan.
  • Liu S; Department of chronic and non-communicable disease, Hangzhou Center for Disease Control an Prevention, Hangzhou, Zhejiang, China.
  • Jiang C; Department of chronic and non-communicable disease, Hangzhou Center for Disease Control an Prevention, Hangzhou, Zhejiang, China.
  • Wang J; Department of expanded program on immunizaiton, Hangzhou Center for Disease Control an prevention, Hangzhou, Zhejiang, China.
  • Liu Y; Department of expanded program on immunizaiton, Hangzhou Center for Disease Control an prevention, Hangzhou, Zhejiang, China.
Hum Vaccin Immunother ; 19(1): 2197839, 2023 12 31.
Article in English | MEDLINE | ID: covidwho-2269368
ABSTRACT
This study aims to describe COVID-19 vaccination coverage and its influential factors in hypertensive patients who were administered by community general practitioners in China. A cross-sectional survey was carried out using data from electronic health record systems. The subjects were hypertensive patients who had been involved in the health management of the Essential Public Health Service (EPHS) program in Hangzhou City, China. As of Aug 3, 2022, the full and booster vaccination rates were 77.53% and 60.97% in randomly selected 96,498 subjects. There were disparities across regions, age, and gender in the distribution of COVID-19 vaccination coverage. Obesity and daily alcohol consumption were factors in the promotion of COVID-19 vaccination. Current smoking, non-daily physical exercise, irregular medication adherence, and comorbidities were risk factors for COVID-19 vaccination. Coverage rates have decreased depending on the number of risk factors. The ORs (95% CI) were 1.78 (1.61 ~ 1.96) of full vaccination and 1.74 (1.59 ~ 1.89) of booster vaccination in subjects with ≥4 risk factors, compared to those without risk factors. In summary, the progress of COVID-19 vaccination among community hypertensive patients lagged behind that of the general population during the same period. Individuals who lived in urban areas, were elderly, and had an irregular medication adherence, comorbidities, and multiple risk factors should be highlighted in the COVID-19 vaccination campaign.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination Coverage / COVID-19 / Hypertension Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Hum Vaccin Immunother Year: 2023 Document Type: Article Affiliation country: 21645515.2023.2197839

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination Coverage / COVID-19 / Hypertension Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Hum Vaccin Immunother Year: 2023 Document Type: Article Affiliation country: 21645515.2023.2197839